Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Savarese

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Anesthesiology|September 1, 1981
The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind studyD M Philbin, J Moss, C W Akins, et al.
Anesthesiology|March 2, 2018
Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy VolunteersJosh D Kaullen, Joel S Owen, Kim L R Brouwer, et al.
Anesthesia and Analgesia|July 1, 1986
Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patientsF M deBros, A Lai, R Scott, et al.
Anesthesiology|March 1, 1989
The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesiaJ J Savarese, H H Ali, S J Basta, et al.
Anesthesiology|September 14, 2018
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-CysteineJohn J Savarese, Hiroshi Sunaga, Jeff D McGilvra, et al.
Anesthesiology|October 18, 2016
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in ManPaul M Heerdt, Hiroshi Sunaga, Joel S Owen, et al.
Anesthesiology|May 1, 1988
The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drugJ J Savarese, H H Ali, S J Basta, et al.
Anesthesia and Analgesia|November 1, 1990
Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesiaD L Dresner, S J Basta, H H Ali, et al.
Anesthesiology|July 29, 2016
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and CatHiroshi Sunaga, John J Savarese, Jeff D McGilvra, et al.
Anesthesiology|April 17, 2004
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacuriumJohn J Savarese, Matthew R Belmont, Mir A Hashim, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Anesthesiology|September 1, 1981
The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind studyD M Philbin, J Moss, C W Akins, et al.
Anesthesiology|March 2, 2018
Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy VolunteersJosh D Kaullen, Joel S Owen, Kim L R Brouwer, et al.
Anesthesia and Analgesia|July 1, 1986
Pharmacokinetics and pharmacodynamics of atracurium during isoflurane anesthesia in normal and anephric patientsF M deBros, A Lai, R Scott, et al.
Anesthesiology|March 1, 1989
The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesiaJ J Savarese, H H Ali, S J Basta, et al.
Anesthesiology|September 14, 2018
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-CysteineJohn J Savarese, Hiroshi Sunaga, Jeff D McGilvra, et al.
Anesthesiology|October 18, 2016
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in ManPaul M Heerdt, Hiroshi Sunaga, Joel S Owen, et al.
Anesthesiology|May 1, 1988
The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drugJ J Savarese, H H Ali, S J Basta, et al.
Anesthesia and Analgesia|November 1, 1990
Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesiaD L Dresner, S J Basta, H H Ali, et al.
Anesthesiology|July 29, 2016
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and CatHiroshi Sunaga, John J Savarese, Jeff D McGilvra, et al.
Anesthesiology|April 17, 2004
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacuriumJohn J Savarese, Matthew R Belmont, Mir A Hashim, et al.
Pageof 8